Results 181 to 190 of about 86,997 (265)

A TLR7 Agonist Conjugated to a Nanofibrous Peptide Hydrogel as a Potent Vaccine Adjuvant. [PDF]

Adv Healthc Mater
Euliano EM, Pogostin BH, Agrawal A, Yu MH, Baryakova TH, Graf TP, Kunkel AA, Cahue KA, Hartgerink JD, McHugh KJ.   +9 more
europepmc   +1 more source

Water-Soluble and Freezable Aluminum Salt Vaccine Adjuvant. [PDF]

Vaccines (Basel)
Abucayon EG, Belikow-Crovetto I, Hussin E, Kim J, Matyas GR, Rao M, Alving CR.   +6 more
europepmc   +1 more source

Vaccine adjuvants [PDF]

Expert Review of Vaccines, 2013
openaire   +1 more source

Levamisole, as a viral vaccine adjuvant, induces robust host defense through the modulation of innate and adaptive immune responses. [PDF]

Front Microbiol
Kim GS, Kwak DY, Kim HW, Shin S, Ko MK, Hwang SY, Park SH, Kim DH, Park JH, Kim SM, Lee MJ.   +10 more
europepmc   +1 more source

Novel approaches for drug development against chronic primary pain: A systematic review

British Journal of Pharmacology, EarlyView.
Abstract Chronic primary pain (CPP) persisting for more than 3 months, associated with significant emotional distress without any known underlying cause, is an unmet medical need. Traditional or adjuvant analgesics do not provide satisfactory pain relief for a great proportion of these patients.
Valéria Tékus, Éva Borbély, Andreas Goebel, Ralf Baron, Zsófia Hajna, Zsuzsanna Helyes   +5 more
wiley   +1 more source

Picrasidine S Induces cGAS-Mediated Cellular Immune Response as a Novel Vaccine Adjuvant. [PDF]

Adv Sci (Weinh)
Ding X, Sun M, Guo F, Qian X, Yuan H, Lou W, Wang Q, Lei X, Zeng W.   +8 more
europepmc   +1 more source

Therapeutic potential of natural products in cancer immunotherapy: Advances and challenges

British Journal of Pharmacology, EarlyView.
This review systematically outlines the mechanisms underlying tumour immunotherapy resistance and elucidates the role of natural products in enhancing therapeutic efficacy as immunomodulatory adjuvants. Abstract Immunotherapy has emerged as a clinically pivotal approach in cancer treatment, but its application remains limited to a small subset of ...
Rao Hu, Kaibin Dai, Zhensheng Lin, Mingfang Ye, Minfeng Chen, Xiaobo Li, Dongmei Zhang   +6 more
wiley   +1 more source

Glycyrrhiza uralensis polysaccharides as a DC-based Vaccine Adjuvant: Enhanced Immunotherapy Combined with PD-1 Blockade

Aili P, Cai S, Chen B, Aobulikasimu N, Han L, Aipire A.   +5 more
europepmc   +1 more source

Development of a New Vaccine Adjuvant System Based on the Combination of the Synthetic TLR4 Agonist FP20 and a Synthetic QS-21 Variant. [PDF]

J Med Chem
Shaik MM, Pasco S, Romerio A, Pifferi C, Sesana S, Re F, Bezuidenhout CX, Bracco S, Fernandez-Tejada A, Anguita J, Peri F.   +10 more
europepmc   +1 more source

From Cold to Hot: Nanozyme‐Based Strategies for Reprogramming the Tumour Immunoenvironment

Cell Proliferation, EarlyView.
Nanozymes, with multi‐enzyme catalytic activities, reprogram the immunosuppressive tumour microenvironment by inducing immunogenic cell death, relieving hypoxia, and depleting antioxidants, effectively converting immunologically “cold” tumours into “hot” ones to boost cancer immunotherapy efficacy.
Yue Wang, Miao Xu, Yongshun Wang, Xuan Lin, Qiang Zhang, Xiaoning Lin, Xin Wu, Cheng Zhang, Wenhua Huang, Jianlin Shen   +9 more
wiley   +1 more source